Failure of nasogastric omeprazole suspension in pediatric intensive care patients

Pediatric Critical Care Medicine

Volumn 6, Issue 2, 2005, Pages 182-187

  Haizlip, Julie A ^a   Lugo, Ralph A ^b,c   Cash, Jared J ^d   Vernon, Donald D ^c,d  

^a UNIVERSITY OF VIRGINIA MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

Critical care; Omeprazole; Pediatric; Peptic ulcer

Indexed keywords

OMEPRAZOLE; SUCRALFATE;

ADOLESCENT; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CHILD HEALTH CARE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DATA ANALYSIS; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; GROUPS BY AGE; HOSPITAL BED; HUMAN; INTENSIVE CARE UNIT; MALE; OPEN STUDY; PATIENT MONITORING; PRIORITY JOURNAL; RISK ASSESSMENT; STOMACH ACID; STOMACH PH; STRESS ULCER; SUSPENSION; TREATMENT FAILURE; TREATMENT INDICATION;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ANTI-ULCER AGENTS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GASTRIC ACIDITY DETERMINATION; HUMANS; HYDROGEN-ION CONCENTRATION; INFANT; INTENSIVE CARE; INTUBATION, GASTROINTESTINAL; MALE; OMEPRAZOLE; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; STOMACH; TREATMENT FAILURE;

EID: 19444388023     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PCC.0000154953.12594.9E     Document Type: Article

References (27)

1. Cook DJ, Fuller HD, Guyatt GH, et al: Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med 1994; 330: 377-381
2. Hillman K: Acute stress ulceration. Anaesth Intens Care 1985; 13:230-240
3. Cochran EB, Phelps SJ, Tolley EA, et al: Prevalence of, and risk factors for, upper gastrointestinal tract bleeding in critically ill pediatric patients. Crit Care Med 1992; 20: 1519-1523
4. Chaibou M, Tucci M, Dugas MA, et al: Clinically significant upper gastrointestinal bleeding acquired in a pediatric intensive care unit: A prospective study. Pediatrics 1998; 102:933-938
5. Lacroix J, Nadeau D, Laberge S, et al: Frequency of upper gastrointestinal bleeding in a pediatric intensive care unit. Crit Care Med 1992; 20:35-42
6. Gedeit RG, Weigle CGM, Havens PL, et al: Control and variability of gastric pH in critically ill children. Crit Care Med 1993; 21: 1850-1855
7. Fennerty MB: Pathophysiology of the upper gastrointestinal tract in the critically ill patient: Rationale for the therapeutic benefits of acid suppression. Crit Care Med 2002; 30:S351-S355
8. Hastings PR, Skillman JJ, Bushnell LS, et al: Antacid titration in the prevention of acute gastrointestinal bleeding: A controlled, randomized trial in 100 critically ill patients. N Engl J Med 1978; 298:1041-1045
9. Priebe HJ, Skillman JJ, Bushnell LS, et al: Antacid versus cimetidine in preventing acute gastrointestinal bleeding. A randomized trial in 75 critically ill patients. N Engl J Med 1980; 302:426-430
10. Harrison AM, Lugo RA, Vernon DD: Gastric pH control in critically ill children receiving intravenous ranitidine. Crit Care Med 1998; 26:1433-1436
11. Bowen JC, Flemming WH, Thompson JC: Increased gastrin release following penetrating central nervous system injury. Surgery 1974; 75:720-724
12. Marchant J, Summers K, McIsaac RL, et al: A comparison of two ranitidine intravenous infusion regimens in critically ill patients. Aliment Pharmacol Ther 1988; 2:55-63
13. Pisegna JR: Pharmacology of acid suppression in the hospital setting: Focus on proton pump inhibition. Crit Care Med 2002; 30: S356-S361
14. Blum RA: Lansoprazole and omeprazole in the treatment of acid peptic disorders. Am J Health Syst Pharm 1996; 53:1401-1415
15. Phillips JO, Metzler MH, Palmieri TL, et al: A prospective study of the simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage. Crit Care Med 1996; 24:1793-1800
16. Barie PS, Hariri RJ: Therapeutic use of omeprazole for refractory stress-induced gastric mucosal hemorrhage. Crit Care Med 1992; 20:899-901
17. Bergman KL, Kaufman S, Collier D, et al: Pharmacodynamics of omeprazole suspension in critically ill pediatric liver/intestinal transplant patients. Crit Care Med 1999; 27: 279
18. Olsen KM, Bergman KL, Kaufman SS, et al: Omeprazole pharmacodynamics and gastric acid suppression in critically ill pediatric transplant patients. Pediatr Crit Care Med 2001; 2:232-237
19. Pollack MM, Patel KM, Ruttimann UE: PRISM III: An updated pediatric risk of mortality. Crit Care Med 1996; 24:743-752
20. Taketomo CK, Hodding JH, Kraus DM: Pediatric Dosing Handbook. Fourth Edition. Houston, Lexi-Comp Inc, 1997
21. Gauvin F, Dugas MA, Chaibou M, et al: The impact of clinically significant upper gastrointestinal bleeding acquired in a pediatric intensive care unit. Pediatr Crit Care Med 2001; 2:294-298
22. Lasky MR, Metzler MH, Phillips JO: A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding form stress ulcers in mechanically ventilated trauma patients. J Trauma 1998; 44:527-533
23. Phillips JO, Olsen KM, Rebuck JA et al: A randomized pharmacokinetic and pharmacodynamic, cross-over study of duodenal or jejunal administration compared to nasogastric administration of omeprazole suspension in patients at risk for stress ulcers. Am J Gastroenterol 2001; 96:367-372
24. Sharma VK, Peyton B, Spears T, et al: Oral pharmacokinetics of omeprazole and lansoprazole after single and repeated doses as intact capsules or as suspensions in sodium bicarbonate. Aliment Pharmacol Ther 2000; 14:887-892
25. Kearns GL, Andersson T, James LP, et al: Omeprazole disposition in children following single-dose administration. J Clin Pharmacol 2003; 43:840-848
26. Netzer P, Gaia C, Sandoz M, et al: Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours. Am J Gastroenterol 1999; 94:351-357
27. Merki HS, Wilder-Smith CH: Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing? Gastroenterology 1994; 106:60-64